about mylan about mylan about mylan about mylan

For customer service and orders


Free phone: 0800 579 811
Free fax: 0800 620 620

Contact a Mylan representative in your area.

  • Region
  • Pharmacy Reps
  • GP Reps
  • Northland,
    North Shore,
    West & Central
    Auckland

  • Sophie MacDonald
    Mobile: 027 256 0057
    sophie.macdonald@mylan.co.nz

  • Mike Hoffman
    Mobile: 021 874 168
    Mike.hoffman@mylan.com

EpiPen® (adrenaline 300mcg/0.3ml) and EpiPen® Jr (adrenaline 150mcg/0.3ml) Auto-Injector. Medicine Classification: Restricted medicine. Indications: For the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, or bites, foods, medications or other allergens. Contraindications: Arrhythmias, cerebral arteriosclerosis; maternal hypertension in excess of 130/80; shock (other than anaphylactic shock), organic brain damage, or during general anaesthesia with halogenated hydrocarbons or cyclopropane, and in patients where vasopressor drugs are contraindicated. Precautions: Patients with allergies to sulphites, cardiac dilation, ventricular brillation, myocardial infarction and other heart conditions, elderly, diabetes and other diseases. Serious skin and soft tissue infections, laceration and embedded needles reported at injection site. Interactions: Concomitant use with other sympathomimetic agents not advised. Caution in combination with CNS agents; TCAs; MAOIs; levothyroxine and thyroid hormones; some antihistamines; alpha-adrenergic blocking agents; beta-adrenergic blocking agents; digoxin; quinidine; general anaesthetics; hypoglycaemic agents. See datasheet for more information and incompatibilities. Adverse Effects: Potentially fatal ventricular arrhythmias, including ventricular brillation may occur and severe hypertension may lead to cerebral haemorrhage and pulmonary oedema. Other symptomatic adverse events can occur. Dosage & Administration: EpiPen® delivers a single 300μg intramuscular dose of adrenaline and should only be used in patients weighing more than 30 kg. EpiPen® Jr delivers a single 150μg intramuscular dose of adrenaline and should only be used in children weighing 15kg to 30kg. EpiPen® and EpiPen® Jr are non-funded medicines. Patients are required to pay the full cost. Before recommending this medicine please refer to full datasheet available from www.medsafe.govt.nz. EpiPen® is a registered trademark of Mylan Inc. Mylan NZ Ltd., Auckland. TAPS DA1726ET-36.